Skip to main content
Share

World's leading clinical conference on bone, joint and muscle health

Programme

Go to Sponsored Sessions

Friday April 11 th - CEST Timezone

08:00
Opening of the Congress & commercial exhibition
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR2
Update in Low Back Pain: Diagnosis, Guidelines and Management
Chairpersons: Fitnat Dincer, Andreas Winkelmann
08:00
MR2
Approach of physiatrists to Low Back Pain in Europe, results of a research and WHO guideline
Fitnat Dincer
08:00
MR2
Update in Diagnosis and Management of Low Back Pain
Andreas Winkelmann
08:00
MR3
Empowering Patients: Integrating Preferences and Perspectives into Osteoporosis Care and Policy Development
Chairperson: Angie Botto-van Bemden
08:00
MR3
What Do We Know About Preferences of Patients at Risk for Fractures?
Lakshmi Nagendra
08:00
MR3
Integrating Patients Preferences and Perspectives into Osteoporosis Care and Policy Development: An Academic Perspective
Mickael Hiligsmann
08:00
MR3
Integrating Patient Preferences and Perspectives into Osteoporosis Care and Policy Development: The Patient Perspective
Angie Botto-van Bemden
08:00
MR4
Muscle And Bone: A Multifaceted Connection
Chairperson: Osvaldo Daniel Messina
08:00
MR4
A message from the bone: how bone-secreted factors affect muscle growth and function
Gustavo Duque
08:00
MR4
The role of fat in muscle/bone crosstalk: an additional complex player
Tiffany Kim
08:00
MR4
A message from the muscle: how muscle-secreted factors affect bone metabolism and function
Osvaldo Daniel Messina
08:00
MR1
Management of osteoporotic vertebral fractures - Risk factor - Guidelines - Technology
Chairpersons: Andreas Kurth, Chistopher Niedhardt
08:00
MR1
Risk factor vertebral fractures
Peyman Hadji
08:00
MR1
German Guidelines for the Treatment of vertebral osteoporotic fractures
Andreas Kurth
08:00
MR1
30 Years of Vertebro- and Kyphoplasty
Robert Pflugmacher
08:00
MR6
Optimization of bone health in orthopaedic surgical patients
Chairperson: P. Dean Cummings
08:00
MR6
Underlying Bone Health: Is it Important to Surgical Outcomes?
P. Dean Cummings
08:00
MR6
Orthopaedic Surgeries Affected by Compromised Bone Health
Nikos Koumontzis
08:00
MR6
Development of Pre- and Post-operative Bone Health Programs for Orthopedic Surgical Patients
Isabella Esposito
08:00
MR7
Hyponatremia and Bone
Chairpersons: Maria Luisa Brandi, Alessandro Peri
08:00
MR7
What did basic research tell us?
Alessandro Peri
08:00
MR7
Hyponatremia and bone density
Laura Potasso
08:00
MR7
Hyponatremia, falls and fractures
Ploutarchos Tzoulis
08:00
MR7
Discussion and Conclusion
08:00
MR8
Discovery, validation and implementation of endophenotyping for patient stratification in osteoarthritis clinical trials
Chairperson: Ali Mobasheri
08:00
MR8
Advancing osteoarthritis trials and therapeutic development through clinical phenotyping and molecular endotyping
Ali Mobasheri
08:00
MR8
Endotyping osteoarthritis by interrogating the pathobiological bioactivity present in osteoarthritic synovial fluid
Tim J. M. Welting
08:00
MR8
Insights into OA endophenotypes from recent clinical trials
Philip Conaghan
08:00
MR8
Obesity shapes the inflammatory molecular endotypes of synovial fibroblasts in osteoarthritis
Simon W. Jones
08:00
MR8
Clinical application of longitudinally stable molecular endotypes in osteoarthritis: pathways to precision medicine
Anne-Christine Bay-Jensen
08:00
MR10
The skeleton in the Closet: A historical look at osteoporosis
Chairperson: Bruno Muzzi Camargos
08:00
MR10
Osteoporosis in Ancient History
Geraldine Altamar
08:00
MR10
Osteoporosis in Art
Andres Coy
08:00
MR10
History of Osteoporosis pharmacological treatment
Michael McClung
08:00 - 09:00
MR5
ESCEO Symposium: Recommendations for an optimal use of Bone Forming Agents in osteoporosis
Chairpersons: Bernard Cortet, Nicola Veronese
08:00
MR5
Which patients should benefit from a Bone Forming Agent?
Elizabeth M. Curtis
08:00
MR5
Comparative efficacy and safety of currently available Bone Forming Agents
René Rizzoli
08:00
MR5
Discussion Leader
Peter R. Ebeling
09:00 - 10:30
Auditorium A
Scientific Session I
Chairpersons: Elaine M. Dennison, Salvatore Minisola
09:00
Auditorium A
Plenary Lecture
Hormone therapy for fracture prevention - a sex stratified approach
Michael McClung
Have a sneak peek
09:30
Auditorium A
Oral communications selected from abstracts
OC1: AGA2118, A BISPECIFIC MONOCLONAL ANTIBODY NEUTRALIZING BOTH SCLEROSTIN AND DKK1, INCREASED BONE FORMATION, DECREASED BONE RESORPTION, AND LED TO RAPID BMD GAINS IN A FIRST IN HUMAN, SINGLE- AND MULTIPLE- DOSE, PLACEBO-CONTROLLED, RANDOMIZED STUDY
Presenting author: B. Langdahl
Authors: M. T. Drake, Y. L. Zhang, J. Z. Ke, Y. F. Li, M. Lankachandra, A. C. Zovein, H. Z. Ke, W. H. Dere & R. E. Dent
09:40
Auditorium A
Oral communications selected from abstracts
OC2: WEEKLY VITAMIN D AND DAILY CALCIUM CARBONATE OVER 48-WEEKS INCREASES BONE DENSITY IN ADOLESCENTS WITH HIV AND 25(OH)D <75NMOL/L: A PLACEBO-CONTROLLED TRIAL IN SOUTHERN AFRICA
Presenting author: C. Gregson
Authors: T. Madanhire, N. V. Dzavakwa, L. Kasonka, H. Banda-Mabuda, T. Bandason, M. Chisenga, S. Filteau, K. Kranzer, H. Mujuru, U. E. Schaible, S. L. Rowland-Jones, V. Simms & R. A. Ferrand
09:50
Auditorium A
Oral communications selected from abstracts
OC3: PTH1 RECEPTOR AGONISTS FOR FRACTURE RISK: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Presenting author: C. Beaudart
Author: N. Veronese, J. Douxfils, J. Amuthavalli Thiyagarajan, F. Bolzetta, P. Albanese, G. Voltan, M. Alokail, N. C. Harvey, N. R. Fuggle, R. Rizzoli & J.-Y. Reginster
10:00
Auditorium A
Oral communications selected from abstracts
OC4: EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY
Presenting author: R. Wagman
Author: G. Burshtein, C. Itin, H. Galitzer, M. Kushnir, M. Toledano, L. Humbert, R. Boyce, S. L. Ferrari & F. Cosman
10:10
Auditorium A
Oral communications selected from abstracts
OC5: SUSTAINED REDUCTION IN FRACTURE RATE IN PATIENTS WITH OI TREATED WITH SETRUSUMAB: FOURTEEN MONTH DATA FROM PHASE 2 OF THE PHASE 2/3 ORBIT STUDY
Presenting author: J. Nowicki
Author: S. Gottesman, O. Carpenter, D. Velasco, M. Wallace, P. Smith, A. Imel, D. Luca, M. Byers, S. Krolczyk & E. M. Lewiecki
10:20
Auditorium A
Oral communications selected from abstracts
OC6: PROGRESSIVE DECREASES IN FRACTURE INCIDENCE WITH ZOLEDRONATE USE >3 YEARS
Presenting author: I. Reid
Author: A. M. Horne, B. Mihov & G. D. Gamble
10:30 - 12:10
Auditorium A
Scientific Session II
Chairpersons: Jean-Marc Kaufman, Maria Luisa Brandi
10:30
Auditorium A
Presentation of the 2025 IOF CSA Medal of Achievement
Eugene McCloskey
10:40
Auditorium A
Plenary Lecture
Anti-resorptives: series or parallel ?
Eugene McCloskey
11:10
Auditorium A
Oral communications selected from abstracts
OC7: COMPREHENSIVE COMPARATIVE ANALYSIS OF INFRAPATELLAR FAT PAD MORPHOLOGIES IN A LONGITUDINAL KNEE OSTEOARTHRITIS STUDY: NEW INSIGHTS INTO ITS ROLE AS A PROGNOSTIC MARKER
Presenting author: J.-P. Pelletier
Author: P. Paiement, F. Abram, M. Dorais, J.-P. Raynauld & J. Martel-Pelletier
11:20
Auditorium A
Oral communications selected from abstracts
OC8: RESULTS FROM A RANDOMISED CONTROLLED PHASE II TRIAL WITH LEVI-04, A NOVEL NEUROTROPHIN-3 INHIBITOR, DEMONSTRATE SUBSTANTIALLY IMPROVED PAIN AND FUNCTION WITHOUT DELETERIOUS EFFECTS ON JOINT STRUCTURE IN PEOPLE WITH KNEE OSTEOARTHRITIS
Presenting author: P. Conaghan
Author: A. Guermazi, N. Katz, A. Bihlet, R. Dror, M. Perkins, B. Hughes, C. Herholdt, I. Bombelka & S. Westbrook
11:30
Auditorium A
Oral communications selected from abstracts
OC9: A PHASE 1B RANDOMIZED CONTROLLED TRIAL EVALUATING SAFETY AND PHARMACODYNAMICS OF A NOVEL IL-1RA GENE THERAPY (GNSC-001) INJECTION IN KNEE OA: 6-MONTH INTERIM RESULTS
Presenting author: J. Tambiah
Author: S. Jackson, M. Concepcion, S. Vijay, T. W. Chalberg, A. Annahita & P. G. Conaghan
11:40
Auditorium A
Oral communications selected from abstracts
OC10: EFFECTIVENESS OF CELECOXIB IN REDUCING OSTEOARTHRITIS (OA) PAIN IN PATIENTS WITH MODERATE AND SEVERE PAIN: ONCE-DAILY VS TWICE-DAILY DOSING
Presenting author: E. Choy
Author: C. Walker, R. Chiaese, E. Biesheuvel & S. Suresh Kumbhar
11:50
Auditorium A
Oral communications selected from abstracts
OC11: 10-YEAR FOLLOW-UP AFTER INTRA-ARTICULAR INJECTIONS OF 2.5 % POLYACRYLAMIDE HYDROGEL FOR KNEE OSTEOARTHRITIS
Presenting author: H. Bliddal
Author: A. Hartkopp, P. Conaghan & M. Henriksen
12:00
Auditorium A
Oral communications selected from abstracts
OC12: EFFECTS OF INTRA-ARTICULAR HYALURONIC ACID INJECTIONS ON PAIN AND FUNCTION IN KNEE OSTEOARTHRITIS PATIENTS: AN UMBRELLA REVIEW OF SYSTEMATIC REVIEWS AND META-ANALYSES OF RANDOMIZED PLACEBO-CONTROLLED TRIALS
Presenting author: O. Bruyère
Author: M. Alokail, N. Al-Daghri, J.-Y. Reginster & S. Sabico
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Fanny Buckinx
14:00
Podium
OP1 - P815: OBESITY IS RELATED TO POORER FUNCTIONAL OUTCOMES AMONG INDIVIDUALS WITH RADIOGRAPHIC KNEE OSTEOARTHRITIS: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: L.D. Westbury
Author: F. Laskou, F. Kirkham-Wilson, G. Bevilacqua, N. R. Fuggle & E. M. Dennison
14:06
Podium
OP2 - P700: DRIVING KNEE OSTEOARTHRITIS STRUCTURAL PROGRESSOR PROGNOSIS INTO THE NEXT GENERATION: LEVERAGING MACHINE/DEEP LEARNING, MICRORNA AND MAGNETIC RESONANCE IMAGING
Presenting author: J. Martel-Pelletier
Author: A. Jamshidi, O. Espin-Garcia, T. G. Wilson, I. Loveless, J.-P. Pellletier & S. A. Ali
14:12
Podium
OP3 - P686: EFFECTIVENESS OF PRESCRIPTION GLUCOSAMINE SULFATE (PGS) IN A COHORT OF FILIPINO PATIENTS WITH MILD-MODERATE KNEE OSTEOARTHRITIS (OA)
Presenting author: J.J. Lichauco
Author: C. Walker, R. Chiaese, H. Scott & S. Venugopal
14:18
Podium
OP4 - P1138: SAFETY OF ANTI-OSTEOARTHRITIS MEDICATIONS: OUTCOMES OF A SYSTEMATIC LITERATURE REVIEW OF POST-MARKETING SURVEILLANCE STUDIES
Presenting author: O. Bruyère
Author: G. Honvo, L. Lengelé, M. Alokail, N. Al-Daghri, J.-Y. Reginster
14:24
Podium
OP5 - P553: EFFECT OF TIBOLONE ON CORTICAL AND TRABECULAR BONE IN POSTMENOPAUSAL WOMEN COMPARED WITH ESTROGEN THERAPY
Presenting author: G.A. Cruz Priego
Author: P. Clark, M.-A. Guagnelli, L. Humbert, S. Ortiz-Santiago, L. Castrejón-Delgado & M. A. Sánchez-Rodriguez
14:30
Podium
OP6 - P817: VERTEBRAL FRACTURES IDENTIFIED ON LATERAL DXA IMAGES USING DEEP NEURAL NETWORKS PREDICT INCIDENT FRACTURES IN OLDER WOMEN
Presenting author: L. Johansson
Authors: V. Wåhlstrand, J. Alvén, I. Häggström & M. Lorentzon
14:36
Podium
OP7 - P381: MACHINE LEARNING FOR THE PREDICTION OF FRAGILITY FRACTURES BY BONE AND BODY COMPOSITION PARAMETERS: FINDINGS FROM THE OSTEOLAUS 10 YEARS POPULATIONAL COHORT
Presenting author: C. Vendrami
Author: G. Gatineau, E. Gonzalez Rodriguez, O. Lamy, D. Hans & E. Shevroja
14:42
Podium
OP8 - P485: REMS TECHNOLOGY FOR FRACTURE RISK ASSESSMENT IN KIDNEY TRANSPLANT PATIENTS
Presenting author: F.A. Lombardi
Author: P. Pisani, F. Conversano, C. Stomaci, F. R. Contaldo, E. Casciaro, G. Peluso, A. C. Stetco, R. Franchini, M. Di Paola & S. Casciaro
14:48
Podium
OP9 - P940: IMPACT OF AI-ENABLED VERTEBRAL FRACTURE (VF) IDENTIFICATION ON FRACTURE LIAISON SERVICE (FLS) KEY PERFORMANCE INDICATORS (KPIS) AND TREATMENT RECOMMENDATIONS VARIES BY FLS
Presenting author: K. Javaid
Author: F. A. A. Clemeno, D. Chappell, J. Connor, J. Threlkeld, C. Chisholm, K. E. S. Poole, J. Boylan, J. Turton, M. Stone, C. Toogood, T. Santos, M. Sampson, M. Baxter, E. Curtis, R. Eckert, O. Sahota, Y. Kimmel & R. Pinedo-Villanueva
14:54
Podium
OP10 - P724: TRENDS IN HIP FRACTURE INCIDENCE IN ENGLAND BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC (2014-2023)
Presenting author: J. Webster
Author: R. Goldacre
14:00 - 15:00
Poster Viewing Session I
14:00 - 15:00
Meet-The-Expert Session
14:00
MR4
Advances in management of osteogenesis imperfecta
Maria Luisa Brandi
14:00
MR1
Influences of parental health on the next generation bone
Elizabeth M. Curtis, Rebecca Moon
14:00
MR2
Paget’s disease of bone: management lessons from pivotal studies
Elaine M. Dennison
14:00
MR3
Fracture risk in cancer survivors: bone fragility beyond metastases
Cyrille Confavreux
14:00 - 15:00
MR8
Educational Lecture
14:00
MR8
Lessons from interventional studies conducted in sarcopenia: are we close to a treatment?
Francesco Landi
14:00 - 15:00
MR6
ESCEO Symposium: Impact of central nervous system dysfunctions (Dementia and Mild Cognitive Impairment) on bone health in older people
Chairpersons: René Rizzoli, Andrea Ticinesi
14:00
MR6
Relation between cognitive impairment and bone health
Mario Miguel Coelho Da Silva Rosa
14:00
MR6
Drugs used in cognitive impairment and bone health
Ewa Balkowiec-Iskra
14:00
MR6
Discussion leader
Maria Concepcion Prieto Yerro
14:00 - 15:00
MR7
ESCEO-IOF-IFCC Symposium: Update on the role of Bone Turnover Markers in the diagnosis and management of osteoporosis
Chairpersons: Andrea Laslop, Etienne Cavalier
14:00
MR7
Why and how should we test biochemical markers of bone turnover in 2025?
Harjit Pal Bhattoa
14:00
MR7
What do bone turnover markers bring to the clinician, in the screening, diagnosis and monitoring of osteoporosis in 2025?
Stuart L. Silverman
14:00
MR7
What is the role of bone turnover markers in Chronic Kidney Disease-related osteoporosis?
Mathias Loberg Haarhaus
14:00
MR7
Discussion leader
Etienne Cavalier
15:00 - 17:00
Auditorium A
Scientific Session III
Chairpersons: Bess Dawson-Hughes, Leith Zakraoui
15:00
Auditorium A
Plenary Lecture
Osteoanabolics: to lump or to split?
Jean-Yves Reginster
Have a sneak peek
15:30
Auditorium A
Oral communications selected from abstracts
OC13: ASSESSING BONE MINERAL DENSITY: A COMPARATIVE STUDY OF DXA AND RADIOFREQUENCY ECHOGRAPHIC MULTI-SPECTROMETRY (REMS) IN ASIAN POPULATION
Presenting author: Y. Yoshino
Author: Y. Asada, E. Tomatsu, S. Sekiguchi-Ueda, S. Shibata, T. Takayanagi, Y. Seino, Y. Sasaki, H. Takai, H. Ito, H. Sasaki & A. Suzuki
15:40
Auditorium A
Oral communications selected from abstracts
OC14: RAPID BONE MICROARCHITECTURE DECLINE, BUT NOT HIGHER FRACTURE RISK, IN MEN WITH ELEVATED FGF23 CONCENTRATION – THE STRAMBO STUDY
Presenting author: P. Szulc
Author: D. Whittier, S. K. Boyd, L. C. Hofbauer & R. Chapurlat
15:50
Auditorium A
Oral communications selected from abstracts
OC15: NUMBER OF FRACTURES AND FRACTURE INCIDENCE IN RELATION TO BONE MINERAL DENSITY: AN INTERNATIONAL META-ANALYSIS
Presenting author: H. Johansson
Authors: N. C. Harvey, E. McCloskey, E. Liu, L. Vandenput, M. Lorentzon, W. D. Leslie, J. A. Kanis & Frax Meta-Analysis Cohort Group
16:00
Auditorium A
Oral communications selected from abstracts
OC16: TYPE I DIABETES MELLITUS IS ASSOCIATED WITH INCREASED FRACTURE RISK INDEPENDENT OF BONE MINERAL DENSITY: AN INTERNATIONAL META-ANALYSIS
Presenting author: N.C. Harvey
Authors: E. M. Curtis, H. Johansson, E. V. McCloskey, E. Liu, L. Vandenput, M. Lorentzon, W. D. Leslie, J. A. Kanis & Frax Meta-Analysis Cohort Group
16:10
Auditorium A
Oral communications selected from abstracts
OC17: EXTERNAL VALIDATION OF AN AI-DRIVEN RADIOGRAPHIC TOOL FOR OPPORTUNISTIC DETECTION OF HIGH BONE FRAGILITY RISK IN DIVERSE INTERNATIONAL COHORTS
Presenting author: G. Gatineau
Author: M. De Gruttola, K. Hind, M- Davies, M. Kužma, J. Payer, G. Guglielmi, A. Fahrleitner-Pammer, KJ. Chun, K. Jones, D. Krueger, N. Binkley & D. Hans
16:20
Auditorium A
Oral communications selected from abstracts
OC18: COST-EFFECTIVENESS OF OPPORTUNISTIC OSTEOPOROSIS SCREENING USING CHEST RADIOGRAPHS WITH DEEP LEARNING IN GERMANY
Presenting author: M. Hiligsmann
Author: J.-Y. Reginster
16:30
Auditorium A
Plenary Lecture
Obesity stratification in personalised osteoporosis management
Peter R. Ebeling
Have a sneak peek
15:00 - 16:45
MR5
Committee of National Societies Special Plenary Session: Fragility Fracture Management – Challenges and Solutions
Chairpersons: Famida Jiwa, Şansin Tüzün
15:10
MR5
OCs1: TARGETING THE MUSCLE–BRAIN AXIS: THE RECIPROCAL RELATIONSHIP BETWEEN COGNITIVE IMPAIRMENT AND SARCOPENIA- DOES IT REPRESENT A NEW PARADIGM IN SARCOPENIA?
Presenting author: Y. El Miedany
Author: N. Gadallah, M. Sarhan, M. Elgaafary, W. Hassan, N. El Gharbawy, S. Moussa, S. Fathi, N. Fouda, D. El Mikkawy, O. Saboony, A. Safar, W. Elwakil, S. Mahran, M. Elkaramany, N. M. Ahmed, M. Y. Mahgoub & A. Samir
15:18
MR5
OCs2: EVIDENCE-BASED JOINT STATEMENT POSITION OF PERIOPERATIVE BONE OPTIMIZATION IN THE ARTHROPLASTY CANDIDATE, FROM 7 NATIONAL SOCIETIES
Presenting author: R.E. Lopez Cervantes
Author: F. Torres-Naranjo, I. Etxebarria-Foronda, C. Ojeda-Thies, F. Linares-Restrepo, M. A. González-Reyes, J. R. Caeiro-Rey & D. E. Garin-Zertuche
15:26
MR5
OCs3: ACCURACY OF ARTIFICIAL INTELLIGENCE FOR VERTEBRAL FRACTURE ASSESSMENT BY DXA SCAN
Presenting author: O. Phruetthiphat
Author: P. Sinlapavilawan & K. Homsapaya
15:34
MR5
OCs4: GLP-1 RECEPTOR AGONISTS AND RISK OF BONE FRACTURES IN ELDERLY PEOPLE WITH TYPE 2 DIABETES
Presenting author: P. Rotman-Pikielny
Author: M. Kasher Meron, T. Hornik-Lurie & G. Twig
15:42
MR5
OCs5: SARCOPENIA AND ELECTROCARDIOGRAPHIC MARKERS OF ARRHYTHMIA RISK IN OLDER ADULTS
Presenting author: D. Seyithanoglu
Author: O. Erdogan, T. Erdogan, Z. Fetullahoglu, D. Erbas Sacar, O. Kumet, S. Ozkok, M. A. Karan & G. Bahat
15:50
MR5
Presentation of the IOF Committee of National Societies Medal
Famida Jiwa, Şansin Tüzün
16:00
MR5
OCs6: AN ARTIFICIAL INTELLIGENCE ALGORITHM TO IMPROVE DIAGNOSIS OF VERTEBRAL FRACTURES EMBEDDED IN FRACTURE LIAISON SERVICES CAN REDUCE FRACTURES AND REDUCE COSTS
Presenting author: R. Pinedo-Villanueva
Author: G. Fabiano, F. Clemeno & M. K. Javaid
16:08
MR5
OCs7: HIGH-DOSE VITAMIN D THERAPY (300,000 IU MONTHLY): IMPLICATIONS FOR OSTEOARTHRITIS, OSTEOPOROSIS AND ARTERIAL STIFFNESS IN VITAMIN-D DEFICIENT PATIENTS
Presenting author: S. Sokolovic
Author: I. Sokolovic-Tahtovic
16:16
MR5
OCs8: DESTRESSING MINDS. STRENGTHENING MUSCLES. YOGA AND ITS EFFECT ON MUSCLE STRENGTH IN HEALTHY INDIVIDUALS. A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Presenting author: P. Bajaj
Authors: L. Nagendra, M. Samuel & M. Chandran
16:24
MR5
OCs9: HIGH-THROUGHPUT SEQUENCING OF BONE METABOLISM GENES AND THEIR ASSOCIATION WITH OSTEOPOROSIS RISK
Presenting author: P. Marozik
Author: A. Rudenka, V. Samokhovec, K. Kobets & E. Rudenka
16:32
MR5
OCs10: SARCOPENIA AND BONE HEALTH PARAMETERS IN POSTMENOPAUSAL WOMEN WITH DIFFERENT TYPES OF OSTEOPOROTIC FRACTURES
Presenting author: N. Grygorieva
Author: A. Musiienko, D. Kurylo & A. Iniushina
18:30 - 19:30
Non-Sponsored Symposia
18:30
MR1
Sedentary Behaviour: Understanding and measuring its importance in muscle-bone health
Chairperson: Mylène Aubertin-Leheudre
18:30
MR1
Assessing sedentary behaviours using the Patient Reported Outcome Measures (PROMS)
Charlotte Beaudart
18:30
MR1
The Impact of Sedentary Behaviour on Physical Capacity across lifetime
Mylène Aubertin-Leheudre
18:30
MR1
The Impact of Sedentary Behaviour Versus Physical Activity on Bone Health
Olivier Bruyère
18:30
MR2
Potential benefits of art, music and dance on bone and muscle health
Chairpersons: Jorge Luis Alberto Morales Torres, Osvaldo Daniel Messina
18:30
MR2
Introduction: Art, Music, Dancing and Health
Osvaldo Daniel Messina
18:30
MR2
Do patients benefit from artistic activities? What’s the evidence?
Jorge Luis Alberto Morales Torres
18:30
MR2
Artists and activism
Jorge Luis Alberto Morales Torres
18:30
MR2
Potential mechanisms for Argentinian Tango and fracture reduction
Kassim Javaid
18:30
MR2
Health professionals and art: For fun only?
18:30
MR2
Conclusions
Jorge Luis Alberto Morales Torres
18:30
MR3
Multiple sclerosis and osteoporosis
Chairperson: Ifigenia Kostoglou-Athanassiou
18:30
MR3
Multiple sclerosis. An autoimmune disease
Ifigenia Kostoglou-Athanassiou
18:30
MR3
Osteoporosis in the context of multiple sclerosis
Lambros Athanassiou
18:30
MR3
Treatment of osteoporosis in the context of multiple sclerosis
Panagiotis Athanassiou
18:30
MR3
Falls and prevention in multiple sclerosis
Yannis Dionyssiotis
18:30
MR4
Vertebral compression fractures: From care to augmentation
Chairpersons: Şansin Tüzün, Ülkü Akarirmak
18:30
MR4
The Impact of Vertebral Compression Fractures
Ülkü Akarirmak
18:30
MR4
Key Rehabilitation Principles in Vertebral Fractures
Şansin Tüzün
18:30
MR4
Bracing in Vertebral Fractures: Myths and Facts
Rana Terlemez
18:30
MR4
Vertebral Augmentation: Who and When?
Çağatay Öztürk
18:30
MR6
Not a cartilage, not a bone, osteoarthritis is a nerve-related condition
Chairpersons: Johanne Martel-Pelletier, Jean-Pierre Pelletier
18:30
MR6
What do we know about osteoarthritis: Does it translate between affected species?
Eric Troncy
18:30
MR6
Somatosensorial and neurological alterations in feline and canine osteoarthritis
Aliénor Delsart
18:30
MR6
Evidence-based efficacy in managing osteoarthritis in companion animals
Eric Troncy
18:30
MR7
Treatment of moving targets: from guidelines into practice
Chairperson: Bruno Muzzi Camargos
18:30
MR7
Guidelines addressing imminent risk strategies
Andrès Felipe Coy Barrera
18:30
MR7
Treatment discontinuation and intermittent use of bisphosphonates
Geraldine Altamar
18:30
MR7
Sequential and combination therapies mostly supported or avoided
Bruno Muzzi Camargos
18:30
MR8
Bone health in patients with prostate cancer on androgen deprivation therapy
Chairpersons: Jean-Jacques Body, René Rizzoli
18:30
MR8
Bone health in patients with non-metastatic prostate cancer on androgen deprivation therapy (ADT) – an Overview
Nicola Napoli
18:30
MR8
Summary of the evidence on bone agents in patients with prostate cancer on ADT
Marlene Chakhtoura
18:30
MR8
Recommendations for the management of patients with prostate cancer on ADT
David Kendler
18:30
MR10
Implementing and maintaining FLS services: (painful) Lessons learned from working with resource constraints and attempting to overcome hurdles
Chairperson: Maria Luisa Brandi
18:30
MR10
Opening Remarks
Maria Luisa Brandi
18:30
MR10
Lessons learned from implementing and maintaining FLS in Singapore
Manju Chandran
18:30
MR10
Lessons learned from mentorship in Switzerland
Thierry Chevalley
18:30
MR10
Navigating Challenges in the Fight For Fracture Liaison Services in South Africa
Teréza Hough
18:30
MR10
Panel Discussion and Closing Remarks
More…